Saturday, January 14, 2017

FGF21 Improves the Adipocyte Dysfunction Related to Seipin Deficiency

http://type2diabetestreatment.net/obesity-help/fgf21-improves-the-adipocyte-dysfunction-related-to-seipin-deficiency/
Skip to main content FGF21 Improves the Adipocyte Dysfunction Related to Seipin Deficiency PreviousNext

  • Article
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF
Loading

Abstract

Fibroblast growth factor 21 (FGF21) was shown to improve metabolic homeostasis, at least partly by controlling white adipocyte profile and adiponectin secretion. Here, we studied its effect on adipocyte dysfunction in the context of Berardinelli-Seip congenital lipodystrophy (BSCL) linked to seipin deficiency. Bscl2−/− mice displayed a progressive adipose tissue loss with aging as evidenced by the altered profile of residual fat pads and the decrease in adiponectin plasma levels in 12- vs. 4-week-old animals. Aiming to prevent this impairment, we treated 6-week-old Bscl2−/− mice with an FGF21 analog (LY2405319) for a period of 28 days. FGF21 treatment increased adiponectin plasma levels and normalized insulin sensitivity in Bscl2−/− mice by improving the white adipose tissue gene expression pattern. To further decipher the molecular pathways altered by seipin deficiency in mature adipocytes, we developed a unique inducible seipin knockdown cell line (SKD). SKD showed chronic activation of the p38 MAPK pathway associated with apoptotic cell death. Interestingly, FGF21 treatment exerted an antistress effect on SKD cells, reducing p38 MAPK phosphorylation and limiting mature adipocyte loss. Our data demonstrate that FGF21 treatment improves the metabolic profile of Bscl2−/− lipodystrophic mice, partly by improving mature adipocyte maintenance through suppression of cellular stress via inhibition of p38 MAPK activity.

Footnotes

  • B.C. and X.P. equally contributed to this study.

  • This article contains Supplementary Data online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db16-0327/-/DC1.

  • Received March 10, 2016.
  • Accepted August 14, 2016.
  • © 2016 by the American Diabetes Association.
http://www.diabetesjournals.org/content/license

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.

View Full Text

Log in using your username and password

PreviousNext Back to top Diabetes: 66 (1)

Current Issue

January 2017, 66(1) Article Alerts Email Article Citation Tools FGF21 Improves the Adipocyte Dysfunction Related to Seipin Deficiency Lucile Dollet, Clara Levrel, Tamer Coskun, Soazig Le Lay, Cedric Le May, Audrey Ayer, Quentin Venara, Andrew C. Adams, Ruth E. Gimeno, Jocelyne Magré, Bertrand Cariou, Xavier Prieur

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

  • Reduction of Hypothalamic Endoplasmic Reticulum Stress Activates Browning of White Fat and Ameliorates Obesity
  • Renal and Systemic Effects of Calorie Restriction in Patients With Type 2 Diabetes With Abdominal Obesity: A Randomized Controlled Trial
  • Increased Interleukin-32 Levels in Obesity Promote Adipose Tissue Inflammation and Extracellular Matrix Remodeling: Effect of Weight Loss

Similar Articles

Type 2 Diabetes Treatment
Type 2 Diabetes Diet
Diabetes Destroyer Reviews
Original Article
#ObesityHelp

No comments:

Post a Comment